Swine flu offers 'extraordinary super immunity'

H1N1 virus Swine flu infection boosted immunity to surprising degrees

Related Stories

People who recover from swine flu may be left with an extraordinary natural ability to fight off flu viruses, findings suggests.

In beating a bout of H1N1 the body makes antibodies that can kill many other flu strains, a study in the Journal of Experimental Medicine shows.

Doctors hope to harness this power to make a universal flu vaccine that would protect against any type of influenza.

Ultimately this could replace the "best guess" flu vaccines currently used.

Such a vaccine is the "holy grail" for flu researchers. Many scientists are already testing different prototypes to put an end to the yearly race to predict coming flu strains and quickly mass produce a new vaccine each flu season.

Dr Patrick Wilson who led the latest research said the H1N1 swine flu virus that reached pandemic levels infecting an estimated 60 million people last year, had provided a unique opportunity for researchers.

Start Quote

This work gives us more confidence that it will be possible to generate a universal flu vaccine”

End Quote Dr Sarah Gilbert Flu vaccine expert at Oxford University

"It demonstrates how to make a single vaccine that could potentially provide immunity to all influenza.

"The surprise was that such a very different influenza strain, as opposed to the most common strains, could lead us to something so widely applicable."

Extraordinary immunity

In the nine patients they studied who had caught swine flu during the pandemic, they found the infection had triggered the production of a wide range of antibodies that are only very rarely seen after seasonal flu infections or flu vaccination.

Five antibodies isolated by the team could fight all the seasonal H1N1 flu strains from the last decade, the devastating "Spanish flu" strain from 1918 which killed up to 50m people, plus a potentially deadly bird flu H5N1 strain.

The researchers believe the "extraordinarily" powerful antibodies were created as the body learned how to fight the new infection with swine flu using its old memory of how to fight off other flu viruses.

Next they plan to examine the immune response of people who were vaccinated against last year's swine flu but did not get sick to see if they too have the same super immunity to flu.

Dr Sarah Gilbert is a expert in viruses at Oxford University and has been testing her own prototype universal flu vaccine.

She said: "Many scientists are working to develop a vaccine that would protect against the many strains of flu virus.

"This work gives us more confidence that it will be possible to generate a universal flu vaccine."

But she said it would take many years for a product to go through the necessary tests and trials.

"It will take at least five years before anything like this could be widely available."

The number of deaths this winter from flu verified by the Health Protection Agency currently is 50, with 45 of these due to swine flu.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Health stories

RSS

Features & Analysis

  • Stained glass of man with swordFrance 1 England 0

    The most important battle you have probably never heard of


  • Golden retriever10 things

    Dogs get jealous, and nine more nuggets from the week's news


  • Pro-Israel demonstrators shout slogans while protesting in Berlin - 25 July 2014Holocaust guilt

    Gaza conflict leaves Germans confused over who to support


  • The emir of Kuwait Sheikh Sabah al-Ahmad al-Jaber al-SabahFreedoms fear

    Growing concern for rights as Kuwait revokes citizenships


Elsewhere on the BBC

  • CastleRoyal real estate

    No longer reserved for kings and queens, some find living in a castle simply divine

Programmes

  • A robot which is due to compete in the 2014 RoboCupClick Watch

    Why robots from 45 countries are playing football in Brazil, plus other technology news

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.